Cargando…
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting
BACKGROUND: Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events. However, on several occasions, the cardiovascular safety of smoking cessation drugs has been questioned. Our goal is to evaluate the effects of smoki...
Autores principales: | Silva, André Pacheco, Scholz, Jaqueline, Abe, Tania Ogawa, Pinheiro, Gabriela Gouveia, Gaya, Patricia Viviane, Pereira, Alexandre Costa, Santos, Paulo Caleb Junior Lima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700597/ https://www.ncbi.nlm.nih.gov/pubmed/26728720 http://dx.doi.org/10.1186/s12872-015-0180-4 |
Ejemplares similares
-
Effects of aging on the effectiveness of smoking cessation medication
por: Scholz, Jaqueline, et al.
Publicado: (2016) -
Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2018) -
Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020) -
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022) -
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
por: Rocha Santos, Juliana, et al.
Publicado: (2015)